drugset / Trial / NCT00320619

Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery

NCT00320619 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Individuals who undergo spine surgery often have a significant loss of blood and may require multiple blood transfusions. Research has shown that epsilon-aminocaproic acid (EACA) may reduce the amount of blood lost during surgery, which would decrease the number of blood transfusions required. This study will evaluate the safety and effectiveness of EACA at reducing blood loss and the need for blood transfusions in individuals undergoing spine surgery.

Timeline

Start
2000-09
Primary completion
2006-02
Completion
2006-02

Outcome

Mixed primary results

paper Mean total allogeneic RBC transfusions were not statistically different between the groups (5.9 units EACA vs. 6.9 units placebo; P = 0.17). PMID 19730217 ↗

paper Mean postoperative RBC transfusions in the EACA group was less (2.0 units vs. 2.8 units placebo; P = 0.03). PMID 19730217 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminocaproic Acid Small molecule 100 mg/kg Intravenous